Has a New Haven biotech startup raised $23 million?
New Haven’s biotech startup focused on brain disease research, Bexorg, has successfully raised $23 million in a Series A funding round. The round was spearheaded...
						
		This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info

